{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T00:51:33Z","timestamp":1760143893699,"version":"build-2065373602"},"reference-count":72,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,3]],"date-time":"2023-11-03T00:00:00Z","timestamp":1698969600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003793","name":"Heart and Lung Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003793","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Swedish Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["La Presse M\u00e9dicale"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.lpm.2023.104192","type":"journal-article","created":{"date-parts":[[2023,10,26]],"date-time":"2023-10-26T20:25:22Z","timestamp":1698351922000},"page":"104192","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Electrical therapies in heart failure: Evolving technologies and indications"],"prefix":"10.1016","volume":"53","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9039-6023","authenticated-orcid":false,"given":"Cecilia","family":"Linde","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"36","key":"10.1016\/j.lpm.2023.104192_bib0001","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","article-title":"2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"42","author":"McDonagh","year":"2021","journal-title":"Eur Heart J"},{"issue":"10","key":"10.1016\/j.lpm.2023.104192_bib0002","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1002\/ejhf.162","article-title":"Age, prognostic impact of QRS prolongation and left bundle branch block, and utilization of cardiac resynchronization therapy: findings from 14,713 patients in the Swedish Heart Failure Registry","volume":"16","author":"Lund","year":"2014","journal-title":"Eur J Heart Fail"},{"issue":"3","key":"10.1016\/j.lpm.2023.104192_bib0003","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1002\/ejhf.2115","volume":"23","author":"Bozkurt","year":"2021","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.lpm.2023.104192_bib0004","doi-asserted-by":"crossref","unstructured":"Glikson M., Cosedis Nielsen J., Brix M., Michowitz Y., Auricchio A., Moche Barbash J.M., Barrabes J.A., Boriani G., Braunschweig F., Brignole M., Burri H., Coats A., Deharo J.C., Delgado V., Diller G.P. ESC EHRA 2021 guidelines in cardiac pacing and cardiac reynchronization therapy. Europace. 2021: euab232. doi: 10.1093\/europace\/euab232.","DOI":"10.1093\/europace\/euab232"},{"issue":"12","key":"10.1016\/j.lpm.2023.104192_bib0005","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1056\/NEJM200103223441202","article-title":"Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay","volume":"344","author":"Cazeau","year":"2001","journal-title":"N Engl J Med"},{"issue":"21","key":"10.1016\/j.lpm.2023.104192_bib0006","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.1056\/NEJMoa032423","article-title":"Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure","volume":"350","author":"Bristow","year":"2004","journal-title":"N Engl J Med"},{"issue":"18","key":"10.1016\/j.lpm.2023.104192_bib0007","doi-asserted-by":"crossref","first-page":"2864","DOI":"10.1161\/01.CIR.0000146336.92331.D1","article-title":"Effects of cardiac resynchronization on disease progression in patients with left ventricular systolic dysfunction, an indication for an implantable cardioverter-defibrillator, and mildly symptomatic chronic heart failure","volume":"110","author":"Abraham","year":"2004","journal-title":"Circulation"},{"issue":"15","key":"10.1016\/j.lpm.2023.104192_bib0008","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1056\/NEJMoa050496","article-title":"The effect of cardiac resynchronization on morbidity and mortality in heart failure","volume":"352","author":"Cleland","year":"2005","journal-title":"N Engl J Med"},{"issue":"23","key":"10.1016\/j.lpm.2023.104192_bib0009","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1016\/j.jacc.2008.08.027","article-title":"Randomized trial of cardiac resynchronization in mildly symptomatic heart failure patients and in asymptomatic patients with left ventricular dysfunction and previous heart failure symptoms","volume":"52","author":"Linde","year":"2008","journal-title":"J Am Coll Cardiol"},{"issue":"14","key":"10.1016\/j.lpm.2023.104192_bib0010","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1056\/NEJMoa0906431","article-title":"Cardiac-resynchronization therapy for the prevention of heart-failure events","volume":"361","author":"Moss","year":"2009","journal-title":"N Engl J Med"},{"issue":"25","key":"10.1016\/j.lpm.2023.104192_bib0011","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1056\/NEJMoa1009540","article-title":"Cardiac-resynchronization therapy for mild-to-moderate heart failure","volume":"363","author":"Tang","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.lpm.2023.104192_bib0012","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1111\/j.1540-8159.1998.tb01096.x","article-title":"Permanent left ventricular pacing with transvenous leads inserted into the coronary veins","volume":"21","author":"Daubert","year":"1998","journal-title":"Pacing Clin Electrophysiol"},{"issue":"10367","key":"10.1016\/j.lpm.2023.104192_bib0013","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1016\/S0140-6736(22)02076-1","article-title":"Safety, tolerability and efficacy of up-titration of guideline-directed medical therapies for acute heart failure (STRONG-HF): a multinational, open-label, randomised, trial","volume":"400","author":"Mebazaa","year":"2022","journal-title":"Lancet"},{"issue":"15","key":"10.1016\/j.lpm.2023.104192_bib0014","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1056\/NEJMoa1306687","article-title":"Cardiac-resynchronization therapy in heart failure with a narrow QRS complex","volume":"369","author":"Ruschitzka","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.lpm.2023.104192_bib0015","first-page":"1858","article-title":"Time course of progressive reverse remodeling in asymptomatic and mildly symptomatic heart failure patients heart failure patients. Results from the REsynchronization reverses Remodeling in Systolic left vEntricular dysfunction (REVERSE) study","volume":"120","author":"St John Sutton","year":"2009","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.lpm.2023.104192_bib0016","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1016\/j.jacc.2009.08.011","article-title":"Cardiac resynchronization therapy prevents disease progression in NYHA Class I and II heart failure patients 24-month results from the European cohort of the REsynchronization reVErses Remodeling in Systolic left vEntricular dysfunction trial","volume":"54","author":"Daubert","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.lpm.2023.104192_bib0017","doi-asserted-by":"crossref","first-page":"2592","DOI":"10.1093\/eurheartj\/eht160","article-title":"Long-term effects of cardiac resynchronization reverses remodelling in asymptomatic and mildly symptomatic heart failure patients. 5-year results from the REsynchronization reverses Remodeling in Systolic left vEntricular dysfunction (REVERSE) study","volume":"33","author":"Linde","year":"2013","journal-title":"Eur Heart J"},{"issue":"Suppl 1","key":"10.1016\/j.lpm.2023.104192_bib0018","doi-asserted-by":"crossref","first-page":"i1","DOI":"10.1093\/europace\/euu300","article-title":"Statistics on the use of cardiac electronic devices and electrophysiological procedures in the European Society of Cardiology countries: 2014 report from the European Heart Rhythm Association","volume":"17","author":"Raatikainen","year":"2015","journal-title":"Europace"},{"issue":"6","key":"10.1016\/j.lpm.2023.104192_bib0019","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1002\/ejhf.1142","article-title":"CRT survey II: an ESC survey of cardiac resynchronization therapy in 11088 patients \u2013 who is doing what to whom and how?","volume":"20","author":"Dickstein","year":"2018","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.lpm.2023.104192_bib0020","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1093\/europace\/euu205","article-title":"Gender and utilization of cardiac resynchronization therapy, and prognostic impact of QRS prolongation and left bundle branch block in heart failure","volume":"17","author":"Linde","year":"2015","journal-title":"Europace"},{"issue":"1","key":"10.1016\/j.lpm.2023.104192_bib0021","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1056\/NEJMoa1609758","article-title":"Declining risk of sudden death in heart failure","volume":"377","author":"Shen","year":"2017","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.lpm.2023.104192_bib0022","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.015139","article-title":"Time to shock the system: moving beyond the current paradigm for primary prevention implantable cardioverter-defibrillator use","volume":"9","author":"Merchant","year":"2020","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.lpm.2023.104192_bib0023","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1093\/eurheartj\/ehl099","article-title":"Longer-term effects of cardiac resynchronization therapy on mortality in heart failure [the CArdiac REsynchronization-Heart Failure (CARE-HF) trial extension phase]","volume":"27","author":"Cleland","year":"2006","journal-title":"Eur Heart J"},{"key":"10.1016\/j.lpm.2023.104192_bib0024","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1056\/NEJMoa1608029","article-title":"Defibrillator implantation in patients with nonischemic systolic heart failure","volume":"375","author":"Kober","year":"2016","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.lpm.2023.104192_bib0025","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/j.jacep.2018.04.015","article-title":"Improving the use of primary prevention implantable cardioverter-defibrillators therapy with validated patient-centric risk estimate","volume":"4","author":"Levy","year":"2018","journal-title":"JACC Clin Electrophysiol"},{"key":"10.1016\/j.lpm.2023.104192_bib0026","doi-asserted-by":"crossref","first-page":"2591","DOI":"10.1093\/eurheartj\/ehac053","article-title":"Survival of patients undergoing cardiac resynchronization with or without defibrillator: the RESET-CRT project","volume":"43","author":"Hadwiger","year":"2022","journal-title":"Eur Heart J"},{"issue":"24","key":"10.1016\/j.lpm.2023.104192_bib0027","doi-asserted-by":"crossref","first-page":"3115","DOI":"10.1001\/jama.288.24.3115","article-title":"Dual chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial","volume":"288","author":"Wilkoff","year":"2002","journal-title":"JAMA"},{"issue":"23","key":"10.1016\/j.lpm.2023.104192_bib0028","doi-asserted-by":"crossref","first-page":"2932","DOI":"10.1161\/01.CIR.0000072769.17295.B1","article-title":"MOde Selection Trial Investigators Adverse effect of ventricular pacing on heart failure and atrial fibrillation among patients with normal baseline QRS duration in a clinical trial of pacemaker therapy for sinus node dysfunction","volume":"107","author":"Sweeney","year":"2003","journal-title":"Circulation"},{"issue":"17","key":"10.1016\/j.lpm.2023.104192_bib0029","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1056\/NEJMoa1210356","article-title":"Biventricular pacing for atrioventricular block and systolic dysfunction","volume":"368","author":"Curtis","year":"2013","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1016\/j.lpm.2023.104192_bib0030","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1002\/ejhf.1235","article-title":"Upgrades from a previous device compared to de novo CRT implantation in the CRT Survey II: a European Society of Cardiology survey of cardiac resynchronization therapy in 11.088 patients","volume":"20","author":"Linde","year":"2018","journal-title":"Eur J Heart Fail"},{"issue":"37","key":"10.1016\/j.lpm.2023.104192_bib0031","doi-asserted-by":"crossref","first-page":"2510","DOI":"10.1093\/eurheartj\/ehv214","article-title":"Early performance of a miniaturized leadless cardiac pacemaker: the Micra Transcatheter Pacing Study","volume":"36","author":"Ritter","year":"2015","journal-title":"Eur Heart J"},{"issue":"12","key":"10.1016\/j.lpm.2023.104192_bib0032","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1093\/eurheartj\/ehab767","article-title":"Leadless vs. transvenous single-chamber ventricular pacing in the Micra CED study: 2-year follow-up","volume":"43","author":"El-Chami","year":"2022","journal-title":"Eur Heart J"},{"key":"10.1016\/j.lpm.2023.104192_bib0033","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa2300080","article-title":"A dual-chamber leadless pacemaker","author":"Knops","year":"2023","journal-title":"New Eng J Med"},{"issue":"5","key":"10.1016\/j.lpm.2023.104192_bib0034","doi-asserted-by":"crossref","first-page":"2972","DOI":"10.1002\/ehf2.12914","article-title":"Differences in clinical characteristics and reported quality of life of men and women undergoing cardiac resynchronization therapy","volume":"7","author":"Wilkoff","year":"2020","journal-title":"ESC Heart Fail"},{"key":"10.1016\/j.lpm.2023.104192_bib0035","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1016\/j.hrthm.2017.08.017","article-title":"Continuous optimization of cardiac resynchronization therapy reduces atrial fibrillation in heart failure patients: results of the Adaptive Cardiac Resynchronization","volume":"14","author":"Birnie","year":"2017","journal-title":"Heart Rhythm"},{"issue":"22","key":"10.1016\/j.lpm.2023.104192_bib0036","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1053\/euhj.2002.3232","article-title":"Comparative effects of permanent biventricular and right-univentricular pacing in heart failure patients with chronic atrial fibrillation","volume":"23","author":"Leclercq","year":"2002","journal-title":"Eur Heart J"},{"issue":"5","key":"10.1016\/j.lpm.2023.104192_bib0037","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1161\/CIRCHEARTFAILURE.112.968867","article-title":"Cardiac resynchronization therapy in patients with permanent atrial fibrillation: results from the Resynchronization for Ambulatory Heart Failure Trial (RAFT)","volume":"5","author":"Healey","year":"2012","journal-title":"Circ Heart Fail"},{"issue":"7","key":"10.1016\/j.lpm.2023.104192_bib0038","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1016\/j.hrthm.2011.02.014","article-title":"Outcomes of cardiac resynchronization therapy in patients with versus those without atrial fibrillation: a systematic review and meta-analysis","volume":"8","author":"Wilton","year":"2011","journal-title":"Hear Rhythm"},{"issue":"6","key":"10.1016\/j.lpm.2023.104192_bib0039","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1016\/j.hrthm.2017.03.024","article-title":"Outcomes of cardiac resynchronization therapy in patients with intermittent atrial fibrillation or atrial flutter in the COMPANION trial","volume":"14","author":"Kalscheur","year":"2017","journal-title":"Heart Rhythm"},{"issue":"6","key":"10.1016\/j.lpm.2023.104192_bib0040","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.jchf.2013.06.003","article-title":"Cardiac resynchronization therapy in patients with atrial fibrillation: the CERTIFY study (cardiac resynchronization therapy in atrial fibrillation patients multinational registry)","volume":"1","author":"Gasparini","year":"2013","journal-title":"JACC Hear Fail"},{"issue":"9","key":"10.1016\/j.lpm.2023.104192_bib0041","first-page":"1549","article-title":"Rationale and design of the BUDAPEST-CRT upgrade study: a prospective, randomized, multicentre clinical trial","volume":"19","author":"Merkely","year":"2017","journal-title":"Europace"},{"key":"10.1016\/j.lpm.2023.104192_bib0042","doi-asserted-by":"crossref","DOI":"10.1002\/ejhf.2609","article-title":"Baseline clinical characteristics of heart failure patients with reduced ejection fraction enrolled in the BUDAPEST-CRT upgrade trial","author":"Merkely","year":"2022","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.lpm.2023.104192_bib0043","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1054\/jcaf.2001.25652","article-title":"Proposal for a new clinical end point to evaluate the efficacy of drugs and devices in the treatment of chronic heart failure","volume":"7","author":"Packer","year":"2001","journal-title":"J Card Fail"},{"key":"10.1016\/j.lpm.2023.104192_bib0044","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1002\/ejhf.2046","volume":"22","author":"Mullens","year":"2020","journal-title":"Eur J Heart Fail"},{"issue":"7","key":"10.1016\/j.lpm.2023.104192_bib0045","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.jacep.2020.11.010","article-title":"Redefining the classifications of response to cardiac resynchronization therapy: results from the REVERSE study","volume":"7","author":"Gold","year":"2021","journal-title":"JACC Clin Electrophysiol"},{"issue":"2","key":"10.1016\/j.lpm.2023.104192_bib0046","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.hrthm.2022.11.016","article-title":"Association of left ventricular remodeling with cardiac resynchronization therapy outcomes","volume":"20","author":"Gold","year":"2023","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.lpm.2023.104192_bib0047","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCULATIONAHA.122.062124","article-title":"CRT improves outcomes in IVCD but not RBBB: a patient level meta-analysis of randomized controlled trials","author":"Friedman","year":"2023","journal-title":"Circulation"},{"issue":"7","key":"10.1016\/j.lpm.2023.104192_bib0048","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1093\/eurheartj\/ehs305","article-title":"Prevalence, correlates, and prognostic significance of QRS prolongation in heart failure with reduced and preserved ejection fraction","volume":"34","author":"Lund","year":"2013","journal-title":"Eur Heart J"},{"issue":"8","key":"10.1016\/j.lpm.2023.104192_bib0049","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1001\/jamainternmed.2014.2717","article-title":"Cardiac resynchronization therapy in women: US Food and Drug Administration meta-analysis of patient-level data","volume":"174","author":"Zusterseel","year":"2014","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.lpm.2023.104192_bib0050","doi-asserted-by":"crossref","first-page":"3547","DOI":"10.1093\/eurheartj\/eht290","article-title":"An individual patient meta-analysis of five randomized trials assessing the effects of cardiac resynchronisation therapy on morbidity and mortality in patients with symptomatic heart failure","volume":"46","author":"Cleland","year":"2013","journal-title":"Eur Heart J"},{"key":"10.1016\/j.lpm.2023.104192_bib0051","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1002\/ejhf.1133","article-title":"The interaction of sex, height, and QRS duration on the effects of cardiac resynchronization therapy on morbidity and mortality: an individual-patient data meta-analysis. results from a case based meta-analysis","volume":"20","author":"Linde","year":"2018","journal-title":"Eur J Heart Fail"},{"issue":"6","key":"10.1016\/j.lpm.2023.104192_bib0052","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1002\/ejhf.2524","article-title":"The effect of cardiac resynchronization without a defibrillator on morbidity and mortality: an individual patient data meta-analysis of COMPANION and CARE-HF","volume":"24","author":"Cleland","year":"2022","journal-title":"Eur J Heart Fail"},{"issue":"9","key":"10.1016\/j.lpm.2023.104192_bib0053","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/j.jacep.2019.06.003","article-title":"Sex-related procedural aspects and complications in CRT Survey II: a European experience in 11\u2032088 patients","volume":"5","author":"Auricchio","year":"2019","journal-title":"JACC Clin Electrophysiol"},{"issue":"4","key":"10.1016\/j.lpm.2023.104192_bib0054","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1093\/europace\/euaa264","article-title":"The evolution of cardiac resynchronization therapy and an introduction to conduction system pacing: a conceptual review","volume":"23","author":"Herweg","year":"2021","journal-title":"Europace"},{"issue":"1","key":"10.1016\/j.lpm.2023.104192_bib0055","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.hrthm.2021.08.033","article-title":"Clinical outcomes of left bundle branch area pacing compared to right ventricular pacing: results from the Geisinger-Rush Conduction System Pacing Registry","volume":"19","author":"Patel","year":"2022","journal-title":"Heart Rhythm"},{"issue":"11","key":"10.1016\/j.lpm.2023.104192_bib0056","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1016\/j.jacep.2021.04.003","article-title":"A randomized trial of his pacing versus biventricular pacing in symptomatic HF patients with left bundle branch block (his-alternative)","volume":"7","author":"Vinther","year":"2021","journal-title":"JACC Clin Electrophysiol"},{"issue":"12","key":"10.1016\/j.lpm.2023.104192_bib0057","first-page":"1736.e1","article-title":"A novel pacing strategy with low and stable output: pacing the left bundle branch immediately beyond the conduction block","volume":"33","author":"Huang","year":"2017","journal-title":"Can J Cardiol"},{"issue":"40","key":"10.1016\/j.lpm.2023.104192_bib0058","doi-asserted-by":"crossref","first-page":"4161","DOI":"10.1093\/eurheartj\/ehac445","article-title":"Left bundle branch area pacing outcomes: the multicentre European MELOS study","volume":"43","author":"Jastrz\u0119bski","year":"2022","journal-title":"Eur Heart J"},{"key":"10.1016\/j.lpm.2023.104192_bib0059","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s10840-012-9727-9","article-title":"Reversal of cardiomyopathy in patients with congestive heart failure secondary to tachycardia","volume":"36","author":"Donghua","year":"2013","journal-title":"J Interv Card Electrophysiol"},{"key":"10.1016\/j.lpm.2023.104192_bib0060","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1093\/eurheartj\/ehaa612","volume":"42","author":"Hindricks","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.lpm.2023.104192_bib0061","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1056\/NEJMoa1707855","article-title":"Catheter ablation for atrial fibrillation with heart failure","volume":"378","author":"Marrouche","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.lpm.2023.104192_bib0062","doi-asserted-by":"crossref","first-page":"3999","DOI":"10.1093\/eurheartj\/ehy555","article-title":"A randomized controlled trial of atrioventricular junction ablation and cardiac resynchronization therapy in patients with permanent atrial fibrillation and narrow QRS","volume":"39","author":"Brignole","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1016\/j.lpm.2023.104192_bib0063","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1038\/nrcardio.2013.114","article-title":"Cardiac contractility modulation therapy in advanced systolic heart failure","volume":"10","author":"Lyon","year":"2013","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.lpm.2023.104192_bib0064","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1016\/j.jchf.2018.04.010","article-title":"A randomized controlled trial to evaluate the safety and efficacy of cardiac contractility modulation","volume":"6","author":"Abraham","year":"2018","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.lpm.2023.104192_bib0065","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/j.cardfail.2011.05.006","article-title":"Subgroup analysis of a randomized controlled trial evaluating the safety and efficacy of cardiac contractility modulation in advanced heart failure","volume":"17","author":"Abraham","year":"2011","journal-title":"J Card Fail"},{"key":"10.1016\/j.lpm.2023.104192_bib0066","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1002\/ejhf.2202","article-title":"Long-term clinical experience with cardiac contractility modulation therapy delivered by the Optimizer Smart system","volume":"7","author":"Kuschyk","year":"2021","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.lpm.2023.104192_bib0067","first-page":"844","article-title":"Sacubitril\/Valsartan and sudden cardiac death according to implantable cardioverter Defibrillator use and Heart Failure Cause","volume":"8","author":"Rohde","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.lpm.2023.104192_bib0068","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1093\/europace\/euab177","article-title":"Association between sodium\u2013glucose cotransporter-2 inhibitors and risk of sudden cardiac death or ventricular arrhythmias: a meta-analysis of randomized controlled trials","volume":"24","author":"Sfairopoulos","year":"2022","journal-title":"Europace"},{"key":"10.1016\/j.lpm.2023.104192_bib0069","doi-asserted-by":"crossref","DOI":"10.1093\/europace\/euad059","article-title":"Timing of cardiac resynchronization therapy implementation","author":"Levya","year":"2023","journal-title":"Europace"},{"key":"10.1016\/j.lpm.2023.104192_bib0071","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.jacc.2017.11.020","article-title":"Impaired recovery of left ventricular function in patients with cardiomyopathy and left bundle branch block","volume":"71","author":"Sze","year":"2018","journal-title":"J Am Coll Cardiol"},{"issue":"10","key":"10.1016\/j.lpm.2023.104192_bib0072","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1002\/ejhf.781","article-title":"Association between demographic, organizational, clinical, and socio-economic characteristics and underutilization of cardiac resynchronization therapy: results from the Swedish Heart Failure Registry","volume":"19","author":"Lund","year":"2017","journal-title":"Eur J Heart Fail"},{"issue":"1","key":"10.1016\/j.lpm.2023.104192_bib0073","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1093\/europace\/euab233","article-title":"Cardiac resynchronization therapy with or without defibrillator in patients with heart failure","volume":"24","author":"Schrage","year":"2022","journal-title":"Europace"}],"container-title":["La Presse M\u00e9dicale"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0755498223000295?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0755498223000295?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T14:09:33Z","timestamp":1760105373000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0755498223000295"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":72,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["S0755498223000295"],"URL":"https:\/\/doi.org\/10.1016\/j.lpm.2023.104192","relation":{},"ISSN":["0755-4982"],"issn-type":[{"type":"print","value":"0755-4982"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Electrical therapies in heart failure: Evolving technologies and indications","name":"articletitle","label":"Article Title"},{"value":"La Presse M\u00e9dicale","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lpm.2023.104192","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"104192"}}